Webcasts
Glycomics/Glycoproteomics for Biopharmaceutical and Biotechnology Industries
March 16th 2022Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.
Mitigate Risk, Increase Speed & Reduce Complexity with Customized Single-Use Systems
February 22nd 2022Tuesday, February 22, 2022 at 11am EST Hear from Parker Hannifin’s experts on how they are mitigating risk, while accelerating timelines, with open architecture and greater processing flexibility using custom single-use systems for vaccines, antibodies, therapeutics, and gene and cell therapies.
Rapid Analysis of mRNA 5’ Capping and Poly-A Tailing with High-Resolution LC-MS
January 11th 2022Tuesday, January, 11th, 2022 at 9am EST | 3pm CET | 2pm GMT Tuesday, January, 11th, 2022 at 2pm EST | 11am PST | 7pm GMToin us in our expert discussion of Rapid Analysis of mRNA 5’ Capping and Poly-A Tailing with High-Resolution LC-MS. See how mRNA capping can be analyzed by LC-MS within 75 minutes!
Why Flexible End-to-End Solutions Succeed in BDS Handling
May 27th 2021*Thursday, May 27, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST* Transportation of your bulk drug substance (BDS) from downstream to the fill/finish site might not be as simple as it sounds. Mostly geographically detached, each batch of BDS is filled into different primary packaging, frozen to sub-zero temperatures, stored, and shipped before it is then thawed and drained at the fill/finish site. *On Demand Until May 27, 2022*
Bridging the Digital Divide to Advance Bio/Pharma Manufacturing and Quality: A Technology Forum
May 25th 2021*Tuesday, May 25, 2021 at 10am EDT* The bio/pharma industry is turning to proven digital technologies used in other industries to plan, develop, and monitor manufacturing processes, as well as in quality, training, and regulatory oversight. In this event, experts discuss how artificial intelligence, remote monitoring, digital twins, and other technologies can be applied to modernize bio/pharma processes and systems. Lessons learned from the pandemic will be shared. *On Demand Until May 25, 2022*
Designing Stability Programs for Drug Substances and Products
April 13th 2021***Live Tuesday, April 13, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST** Designing a successful stability program can go a long way towards getting your drug product or substance to market. Join this webinar to receive guidance on designing stability testing programs and overcoming potential challenges. *On Demand until April 13, 2022*
Profiling the HLA-II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein Using Mass Spectrometry.
March 30th 2021***Available Now!*** In this webinar, Mike Knierman, Eli Lilly, will discuss the use of mass spectrometry to identify unique sequences from SARS-CoV-2 spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen presenting cells from healthy donors. This work exemplifies the value-add of mass spectrometry in vaccine development. *On Demand until March 30, 2022*
